Financials
Financial year 2025
P&R Medical from Diepenbeek, company number BE0439530358, closed financial year 2025 with a result of € 751,783 after tax. For that financial year P&R Medical recorded a gross margin of € 1.2 million and equity of € 3 million. Compared with financial year 2024, the result moved from € 851,792 to € 751,783. The company is profitable. The buffer shrank hard: equity is 55 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
€ 3 million
▼ 55% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 751,783
▼ 12% vs 2024
Profit after tax over the fiscal year.
€ 1.2 million
▼ 2% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 4.5 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
1
Average over the fiscal year, from the social balance sheet.
€ 109,882
▲ 4% vs 2024
€ 109,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 509
▼ 40% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 423,653
▲ 34% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 13,221
▼ 82% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,463,487 | € 1,138,086 | € 1,340,859 | € 1,231,008 | ▼ 8% |
| Profit after taxes | € 1,000,660 | € 662,657 | € 851,792 | € 751,783 | ▼ 12% |
| Equity | € 5,210,399 | € 5,873,056 | € 6,724,848 | € 2,996,475 | ▼ 55% |
| Total debts | € 700,239 | € 645,354 | € 388,772 | € 437,250 | ▲ 12% |
| Cash | € 1,723,400 | € 1,021,920 | € 1,239,674 | € 1,210,257 | ▼ 2% |
| Retained profit | € 5,191,799 | € 5,854,456 | € 6,706,248 | € 2,977,875 | ▼ 56% |
| Dividend | € 0 | € 0 | € 0 | € 4,480,156 | |
| Balance sheet total | € 5,910,638 | € 6,518,411 | € 7,113,619 | € 3,433,726 | ▼ 52% |
| Employees (FTE) | 1.1 | 1 | 1 | 1 |
Key figures of P&R Medical, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to P&R Medical?
What happened at P&R Medical in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 751,783 (▼ 12% vs 2024). Source: NBB ↗
- ILC NEWCO IV BV became a director. NBB
- New establishment in Diepenbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 1 million profit in 2022 to € 751,783 profit in 2025.
Paid € 1.1 million in corporate taxes since 2022.
Best year ever: 2022, with € 1 million profit.
On average € 1.2 million of value added per employee in 2025.
A new publication or filing at P&R Medical? We notify you, reason included.
Follow P&R MedicalDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of P&R Bidco comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
P&R MedicalBehind P&R Medical is ILC NEWCO IV BV. The shares are held by P&R Bidco (100%).
Establishments
Establishment units
Physical locations of this company
Wetenschapspark 5
3590 Diepenbeek
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0439.530.358
- VAT number
- BE 0439.530.358
- Registered office
- Wetenschapspark 5, 3590 Diepenbeek
- Names & denominations
- P&R Medical
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 January 1990
- Peppol
- Active · Active since 5 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten